首页> 外国专利> Preparation of modified release of Naproxen Sodium

Preparation of modified release of Naproxen Sodium

机译:萘普生钠缓释制剂的制备

摘要

The present Invention is a formulation that Naproxen has a release profile that provides immediate Relief of Pain equivalent to 440 mg (2 Tablets of Naproxen S 220 mg)u00f3dico and also extended Pain Relief during 24 hours.In particular,The present Invention is an individual who combines a Solid dose proportion only a product of immediate release of Naproxen Sodium with a layer of extended release of Naproxen su00f3diCo.More particularly,The present Invention is a two-layer tablet. It immediately releases 300 to 320 mg of Naproxen Sodium and then gradually releases 450 480 mg Naproxen Sodium.This product is able to provide 24 hours of Pain Relief when given as one Tablet two individual layers.The two individual compressed layers provides Immediate Release (IR) of Naproxen Sodium for pain relief of the initial Layer followed by Continuous release of Naproxen Sodium rEmanente of another Layer to maintain the spread of Pain Relief for up to 24 hours.
机译:本发明是这样一种制剂,其萘普生具有释放特性,该特性可立即缓解相当于440 mg的疼痛(2片萘普生S 220 mg),并在24小时内延长了疼痛的缓解时间。个人将固体剂量比例仅是萘普生钠的立即释放产物与萘普生s u00f3diCo的缓释层相结合的个体。更具体地,本发明是两层的片剂。它会立即释放300至320毫克的萘普生钠,然后逐渐释放450 480毫克的萘普生钠。当以片剂的形式分为两层时,该产品能够提供24小时的疼痛缓解。两层压缩层可立即释放(IR )萘普生钠以缓解初始层的疼痛,然后连续释放另一层的萘普生钠的残留,以维持疼痛缓解的扩散长达24小时。

著录项

  • 公开/公告号CR20180209A

    专利类型

  • 公开/公告日2018-08-09

    原文格式PDF

  • 申请/专利权人 BAYER HEALTHCARE LLC;

    申请/专利号CR20180209

  • 发明设计人 SIRIHORACHAI RACHAN;ROSAR PAUL;

    申请日2015-10-09

  • 分类号A61K9/24;A61K31/192;

  • 国家 CR

  • 入库时间 2022-08-21 12:53:07

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号